IP Library › Patent Application 62949773
Patent Application Provisional Small
App. No. 62/949,773 · Confirmation No. 6708

DRUG DELIVERY SYSTEMS COMPRISING A NEUROTROPHIC AGENT, AN APOPTOSIS SIGNALING FRAGMENT INHIBITOR (FAS) OR FAS LIGAND (FASL) INHIBITOR, A TUMOR NECROSIS FACTOR-ALPHA (TNF-ALPHA) OR TNF RECEPTOR INHIBITOR, A MITOCHONDRIAL PEPTIDE, AN OLIGONUCLEOTIDE, A CHEMOKINE INHIBITOR, OR A CYSTEINE-ASPARTIC PROTEASE

Provisional Application Expired
⬇ PDF
 Code Description Pages PDF
2020-09-25 N570 Communication - Re: Power of Attorney (PTOL-308) 1 View
2020-09-22 N417 Electronic Filing System Acknowledgment Receipt 2 View
2020-09-22 PA.. Power of Attorney 2 View
2020-09-22 R3.73 Assignee showing of ownership per 37 CFR 3.73 2 View
2019-12-31 APP.FILE.REC Filing Receipt 3 View
2019-12-18 TRAN.LET Transmittal Letter 1 View
2019-12-18 ADS Application Data Sheet 8 View
2019-12-18 ABST Abstract 1 View
2019-12-18 CLM Claims 3 View
2019-12-18 SPEC Specification 67 View
2019-12-18 WFEE Fee Worksheet (SB06) 2 View
2019-12-18 N417 Electronic Filing System Acknowledgment Receipt 3 View
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this application's details
Quick Facts
App. No.
62/949,773
Filed
2019-12-18